Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 109.8905 deferred stock units, increasing his direct beneficial ownership.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., acquired 109.8905 Deferred Stock Units (DSUs).
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The DSUs were acquired at a price of $25.2 per unit.
• Following this transaction, Simmons directly beneficially owns 19,068.9056 deferred stock units.
• These units are scheduled to become exercisable or settle on February 6, 2026, in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive, routine disclosure. While the amount is small, an executive acquiring company equity, even through compensation, generally signals confidence and aligns interests.

Positives

• The acquisition of deferred stock units by the CEO aligns management's interests with those of shareholders.

Future Outlook

No specific future outlook or guidance was provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions of equity-linked compensation, are common in the animal health industry as a means to incentivize executives and align their long-term interests with company performance. This specific transaction is a routine compensation disclosure.

Comparison to Industry Standards

• This is a standard executive compensation disclosure. No specific comparable companies or projects are mentioned in the filing to allow for a detailed comparison.

Related Party Transactions

• Acquisition of deferred stock units by the CEO as part of an executive compensation plan.

Stakeholder Impact

• Shareholders: Increased alignment of CEO's financial interests with long-term company performance.
• Employees: No direct impact beyond general executive compensation practices.

Next Steps

• The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan, with an exercisable/expiration date of February 6, 2026.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by the CEO as part of an executive compensation plan. While it indicates alignment of interests, the transaction size is not significant enough to alter the fundamental investment thesis for Elanco Animal Health Inc. Investors should consider broader company performance and market conditions rather than this single, expected insider filing.

Keywords

Elanco Animal Health, ELAN, Jeffrey N. Simmons, Deferred Stock Units, DSU, Insider Trading, Executive Compensation, SEC Form 4, Beneficial Ownership